TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
QUIA PHARMA AB (publ)
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
0
![]() |
0
|
157 |
Financial expenses |
680
|
2,870
|
1,768 |
Earnings before taxes |
-11,098
|
-13,424
|
-14,543 |
EBITDA |
-7,827
|
-8,303
|
-11,174 |
Total assets |
28,183
|
15,665
|
17,280 |
Current assets |
1,185
|
2,514
|
4,574 |
Current liabilities |
17,939
|
3,891
|
4,886 |
Equity capital |
10,244
|
1,612
|
17 |
- share capital |
15,655
|
15,833
|
31,028 |
Employees (average) |
3
|
4
|
5 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
36.3%
|
10.3%
|
0.1% |
Turnover per employee |
0
![]() |
0
|
31 |
Profit as a percentage of turnover | -9263.1% | ||
Return on assets (ROA) |
-37.0%
|
-67.4%
|
-73.9% |
Current ratio |
6.6%
|
64.6%
|
93.6% |
Return on equity (ROE) |
-108.3%
|
-832.8%
|
-85547.1% |
Change turnover |
0
|
-144
|
-1,196 |
Change turnover % |
-100%
|
-88% | |
Chg. No. of employees |
-1
![]() |
-1
|
2 |
Chg. No. of employees % |
-25%
|
-20%
|
67% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.